ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for esophageal cancer: triple therapy trial launches
Disease control Not yet recruitingThis study tests a new combination of drugs (SYS6010 and SG001) with or without chemotherapy as a first treatment for people with advanced or metastatic esophageal squamous cell carcinoma. About 737 adults aged 18-75 who have not had prior treatment for advanced disease will part…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated May 17, 2026 03:31 UTC
-
New hope for esophageal cancer: combo therapy enters late-stage trial
Disease control Not yet recruitingThis study tests a new drug combination (BL-B01D1 plus tislelizumab, with or without 5-FU) against standard chemotherapy for people with advanced esophageal cancer that cannot be removed by surgery. About 90 adults will participate. The goal is to see if the new combination helps…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 03:25 UTC
-
New drug combo shows promise against tough esophageal cancer
Disease control Not yet recruitingThis study tests a new drug called Ivonescimab, combined with chemotherapy, given before surgery to people with a type of esophageal cancer that can be removed. The goal is to see if this combination can shrink or eliminate the tumor before surgery, improving long-term outcomes. …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 17, 2026 03:25 UTC
-
Promising drug cocktail aims to boost esophageal cancer surgery success
Disease control Not yet recruitingThis study tests whether giving a combination of three drugs (camrelizumab, chemotherapy, and ivarmacitinib) before surgery can help people with a type of esophageal cancer. The goal is to shrink or eliminate tumors before removal, potentially improving outcomes. About 45 adults …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Morning or afternoon? timing of immunotherapy may impact esophageal cancer outcomes
Disease control Not yet recruitingThis study looks at whether giving immunotherapy in the morning versus the afternoon affects how well it works for people with a type of esophageal cancer. About 90 patients will get the same combination of drugs, but at different times of day. The goal is to see if timing can im…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New shot for tough esophageal cancer enters first human tests
Disease control Not yet recruitingThis early-phase study tests a new drug called IPM514 in people with advanced esophageal cancer that has spread or come back. The main goal is to see if the drug is safe and to find the best dose. About 36 adults will receive the drug as a shot, with doses increasing in small gro…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Beijing Immupeutics Medicine Technology Limited • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Scientists to map tumor changes after Chemo-Immunotherapy in esophageal cancer
Knowledge-focused Not yet recruitingThis study looks at how the area around tumors changes in people with esophageal cancer after they receive standard chemotherapy plus immunotherapy before surgery. Researchers will collect tumor samples before and after treatment and use advanced techniques to study cells and the…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Nanjing Medical University • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC
-
New study aims to make allergy testing safer for cancer patients on biologics
Knowledge-focused Not yet recruitingThis study involves 70 patients with various cancers who are receiving biotherapy drugs. Researchers want to find the highest safe concentration of these drugs to use in skin allergy tests, so they can better diagnose allergic reactions. The goal is to create clear guidelines for…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC